Yes. That is why we all can't be rocket scientists.
Now, does the study also give indication of the probability that this target level of improvement (reached by 40 and 31 percent respectively) would be met by a person who is told they are getting Antegren, but in truth are given a sugar pill?
And, if you get that right, the final question.
If a man voices his opinion in the middle of the woods, where no woman can hear him, will he still be wrong?
post script. I would expect some sort of press on these results in the next few weeks. Elan and Biogen will not lead, given the fact that Antegren Crohn's remains alive with the FDA, but outside researchers and industry publications should be commenting.
Chevy, enough already. the difference is statistically significant. It's not 40 vs 31%, its that the results show that the drug works. And it has a good safety profile. That is all the FDA cares about.
I understand that. my dad got some drug that was risky and could cause death and he agreed but died a day later. I'm just saying the difference is small and that the FDA might not like that at all.